跳至主要内容
临床试验/NCT04222868
NCT04222868Unknown不适用

Indonesian Registry on Atrial Fibrillation

Indonesian Heart Rhythm Society25 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
25
主要终点
Number of Participants with Major Adverse Cardiovascular Events

研究概览

简要总结

Our rationale of creation of this registry stems from the fact that the use of VKA in patients with AF is a double-edged sword, physicians face tremendous burden in assigning patients with VKA, due to risk of Bleeding complications despite its potential benefit. We intend to seek a safe and beneficial range of INR on Indonesian patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years old
  • Diagnosis of valvular or nonvalvular AF

排除标准

  • Reversible AF
  • Patients who have been enrolled as a respondent on other clinical studies

结局指标

主要结局

Number of Participants with Major Adverse Cardiovascular Events

时间窗: 24 months

Major Adverse Cardiovascular Events including stroke/transient ischemic attack, thromboembolism, acute coronary syndrome

Number of Participants with Bleeding Events

时间窗: 24 months

Intracranial bleeding, gastrointestinal bleeding

Mortality Rate

时间窗: 24 months

All-cause Mortality

次要结局

未报告次要终点

研究者

发起方
Indonesian Heart Rhythm Society
申办方类型
Other
责任方
Sponsor

研究点 (25)

Loading locations...

相似试验

Indonesian Registry on Atrial Fibrillation | 临床试验